Comparative Evaluation of the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes and Platelet-Rich Plasma: An In Vitro Analysis
by
Philipp Moog 1, Katharina Kirchhoff 1
, Sanjar Bekeran 1, Anna-Theresa Bauer 1, Sarah von Isenburg 2, Ulf Dornseifer 1,3, Hans-Günther Machens 1,*, Arndt F. Schilling 4,† and Ektoras Hadjipanayi 1,†
Philipp Moog 1, Katharina Kirchhoff 1, Sanjar Bekeran 1, Anna-Theresa Bauer 1, Sarah von Isenburg 2, Ulf Dornseifer 1,3, Hans-Günther Machens 1,*, Arndt F. Schilling 4,† and Ektoras Hadjipanayi 1,†
1
Experimental Plastic Surgery, Clinic for Plastic, Reconstructive and Hand Surgery, Klinikum Rechts der Isar, Technische Universität München, D-81675 Munich, Germany
2
Department of Plastic, Reconstructive, Hand and Burn Surgery, Bogenhausen Hospital, D-81925 Munich, Germany
3
Department of Plastic, Reconstructive and Aesthetic Surgery, Isar Klinikum, D-80331 Munich, Germany
4
Department of Trauma Surgery, Orthopedics and Plastic Surgery, Universitätsmedizin Göttingen, D-37075 Göttingen, Germany
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Biomedicines 2020, 8(1), 16; https://doi.org/10.3390/biomedicines8010016
Received: 4 November 2019 / Revised: 8 January 2020 / Accepted: 10 January 2020 / Published: 16 January 2020
(This article belongs to the Special Issue Hypoxia-Inducible Factors: Regulation and Therapeutic Potential)
Blood-derived factor preparations are being clinically employed as tools for promoting tissue repair and regeneration. Here we set out to characterize the in vitro angiogenic potential of two types of frequently used autologous blood-derived secretomes: platelet-rich plasma (PRP) and hypoxia preconditioned plasma (HPP)/serum (HPS). The concentration of key pro-angiogenic (VEGF) and anti-angiogenic (TSP-1, PF-4) protein factors in these secretomes was analyzed via ELISA, while their ability to induce microvessel formation and sprouting was examined in endothelial cell and aortic ring cultures, respectively. We found higher concentrations of VEGF in PRP and HPP/HPS compared to normal plasma and serum. This correlated with improved induction of microvessel formation by PRP and HPP/HPS. HPP had a significantly lower TSP-1 and PF-4 concentration than PRP and HPS. PRP and HPP/HPS appeared to induce similar levels of microvessel sprouting; however, the length of these sprouts was greater in HPP/HPS than in PRP cultures. A bell-shaped angiogenic response profile was observed with increasing HPP/HPS dilutions, with peak values significantly exceeding the PRP response. Our findings demonstrate that optimization of peripheral blood cell-derived angiogenic factor signalling through hypoxic preconditioning offers an improved alternative to simple platelet concentration and release of growth factors pre-stored in platelets.
View Full-Text
Keywords:
peripheral blood cells; blood-derived therapy; hypoxia; angiogenesis; platelet rich plasma (PRP); hypoxia preconditioned plasma; hypoxia preconditioned serum
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Moog, P.; Kirchhoff, K.; Bekeran, S.; Bauer, A.-T.; von Isenburg, S.; Dornseifer, U.; Machens, H.-G.; Schilling, A.F.; Hadjipanayi, E. Comparative Evaluation of the Angiogenic Potential of Hypoxia Preconditioned Blood-Derived Secretomes and Platelet-Rich Plasma: An In Vitro Analysis. Biomedicines 2020, 8, 16.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
